120 related articles for article (PubMed ID: 1812897)
1. Activation markers on peripheral blood T cells from patients with active or inactive systemic lupus erythematosus. Correlation with proliferative responses and production of IL-2.
Alcocer-Varela J; Alarcón-Riquelme M; Laffón A; Sánchez-Madrid F; Alarcón-Segovia D
J Autoimmun; 1991 Dec; 4(6):935-45. PubMed ID: 1812897
[TBL] [Abstract][Full Text] [Related]
2. Anti-dsDNA production coincides with concurrent B and T cell activation during development of active disease in systemic lupus erythematosus (SLE).
Spronk PE; Horst G; Van Der Gun BT; Limburg PC; Kallenberg CG
Clin Exp Immunol; 1996 Jun; 104(3):446-53. PubMed ID: 9099929
[TBL] [Abstract][Full Text] [Related]
3. B cell hyperactivity is a function of T cell derived cytokines in systemic lupus erythematosus.
al-Janadi M; Raziuddin S
J Rheumatol; 1993 Nov; 20(11):1885-91. PubMed ID: 7508509
[TBL] [Abstract][Full Text] [Related]
4. Enhanced CD3-mediated T lymphocyte proliferation in patients with systemic lupus erythematosus.
Stekman IL; Blasini AM; Leon-Ponte M; Baroja ML; Abadi I; Rodriguez MA
Arthritis Rheum; 1991 Apr; 34(4):459-67. PubMed ID: 1826426
[TBL] [Abstract][Full Text] [Related]
5. Expression of costimulatory molecules on peripheral blood lymphocytes of patients with systemic lupus erythematosus.
Bijl M; Horst G; Limburg PC; Kallenberg CG
Ann Rheum Dis; 2001 May; 60(5):523-6. PubMed ID: 11302879
[TBL] [Abstract][Full Text] [Related]
6. OKT4+ T cell abnormality in patients with active systemic lupus erythematosus: HLA-DR antigen expressions.
Raziuddin S; Danial HB; Kelley M
Clin Immunol Immunopathol; 1988 Jul; 48(1):42-9. PubMed ID: 3260161
[TBL] [Abstract][Full Text] [Related]
7. Characterization of CD3+ CD4- CD8- (double negative) T cells in patients with systemic lupus erythematosus: activation markers.
Anand A; Dean GS; Quereshi K; Isenberg DA; Lydyard PM
Lupus; 2002; 11(8):493-500. PubMed ID: 12220103
[TBL] [Abstract][Full Text] [Related]
8. Correlation between the phenotype and the functional capacity of activated T cells in patients with active systemic lupus erythematosus.
Volk HD; Kopp J; Körner IJ; Jahn S; Grunow R; Barthelmes H; Fiebig H
Scand J Immunol; 1986 Jul; 24(1):109-14. PubMed ID: 3014641
[TBL] [Abstract][Full Text] [Related]
9. An unusual T-cell surface phenotype in vivo correlates with the failure to proliferate and produce IL-2 in vitro in a patient with common variable immunodeficiency.
Vukmanović S; Vucković S; Stosić-Grujicić S; Ramić Z; Abinun M
Clin Immunol Immunopathol; 1992 Dec; 65(3):261-70. PubMed ID: 1280540
[TBL] [Abstract][Full Text] [Related]
10. Cell cycling in HIV infection: analysis of in vivo activated lymphocytes.
Mahalingam M; Pozniak A; McManus TJ; Vergani D; Peakman M
Clin Exp Immunol; 1995 Dec; 102(3):481-6. PubMed ID: 8536361
[TBL] [Abstract][Full Text] [Related]
11. T lymphocytes from patients with systemic lupus erythematosus show increased response to interleukin-2 after costimulation with OKT3 monoclonal antibody and phorbol esters.
Blasini AM; Stekman IL; Gonzalez F; Tositti ML; Rodriguez MA
Clin Immunol Immunopathol; 1994 Jan; 70(1):66-72. PubMed ID: 8261671
[TBL] [Abstract][Full Text] [Related]
12. Characterization of cytokine production, screening of lymphocyte subset patterns and in vitro apoptosis in healthy and Alzheimer's Disease (AD) individuals.
Lombardi VR; García M; Rey L; Cacabelos R
J Neuroimmunol; 1999 Jun; 97(1-2):163-71. PubMed ID: 10408971
[TBL] [Abstract][Full Text] [Related]
13. Impaired expression of high affinity interleukin 2 receptor on activated lymphocytes from patients with systemic lupus erythematosus.
Ishida H; Kumagai S; Umehara H; Sano H; Tagaya Y; Yodoi J; Imura H
J Immunol; 1987 Aug; 139(4):1070-4. PubMed ID: 3112222
[TBL] [Abstract][Full Text] [Related]
14. Disturbed peripheral B lymphocyte homeostasis in systemic lupus erythematosus.
Odendahl M; Jacobi A; Hansen A; Feist E; Hiepe F; Burmester GR; Lipsky PE; Radbruch A; Dörner T
J Immunol; 2000 Nov; 165(10):5970-9. PubMed ID: 11067960
[TBL] [Abstract][Full Text] [Related]
15. Defective clonogenic potential of CD8+ T lymphocytes in patients with AIDS. Expansion in vivo of a nonclonogenic CD3+CD8+DR+CD25- T cell population.
Pantaleo G; Koenig S; Baseler M; Lane HC; Fauci AS
J Immunol; 1990 Mar; 144(5):1696-704. PubMed ID: 2137842
[TBL] [Abstract][Full Text] [Related]
16. PHA-T cells in systemic lupus erythematosus and in rheumatoid arthritis: abnormalities in HLA class II antigen induction and in autologous mixed lymphocyte reactions.
Indiveri F; Scudeletti M; Pierri I; Traverso A; Cerri C; Ferrone S
Cell Immunol; 1986 Jan; 97(1):197-203. PubMed ID: 2943425
[TBL] [Abstract][Full Text] [Related]
17. Fas (CD95)-transduced signal preferentially stimulates lupus peripheral T lymphocytes.
Sakata K; Sakata A; Vela-Roch N; Espinosa R; Escalante A; Kong L; Nakabayashi T; Cheng J; Talal N; Dang H
Eur J Immunol; 1998 Sep; 28(9):2648-60. PubMed ID: 9754553
[TBL] [Abstract][Full Text] [Related]
18. Subsets of activated T cells in patients with systemic lupus erythematosus: the relation to cell cycle.
Tokano Y; Morimoto S; Hishikawa T; Murashima A; Abe M; Sekigawa I; Takasaki Y; Hashimoto H; Okumura K; Shirai T; Hirose S
Scand J Rheumatol; 1997; 26(1):37-42. PubMed ID: 9057800
[TBL] [Abstract][Full Text] [Related]
19. Activated T lymphocytes in the peripheral blood of patients with systemic lupus erythematosus induce B cells to produce immunoglobulin.
Inghirami G; Simon J; Balow JE; Tsokos GC
Clin Exp Rheumatol; 1988; 6(3):269-76. PubMed ID: 3263240
[TBL] [Abstract][Full Text] [Related]
20. Longitudinal study on the production of and cellular response to interleukin-2 in patients with systemic lupus erythematosus.
Alcocer-Varela J; Alarcón-Segovia D
Rheumatol Int; 1995; 15(2):57-63. PubMed ID: 7481481
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
